These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils. Hall ED; Pazara KE; Braughler JM Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306 [TBL] [Abstract][Full Text] [Related]
15. Consistency of cerebral blood flow and evoked potential alterations with reversible focal ischemia in cats. Matsumiya N; Koehler RC; Traystman RJ Stroke; 1990 Jun; 21(6):908-16. PubMed ID: 2349595 [TBL] [Abstract][Full Text] [Related]
16. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats. Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats. Miyabe M; Kirsch JR; Nishikawa T; Koehler RC; Traystman RJ Crit Care Med; 1997 Jun; 25(6):1037-43. PubMed ID: 9201058 [TBL] [Abstract][Full Text] [Related]
18. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs. Davis S; Helfaer MA; Traystman RJ; Hurn PD Stroke; 1997 Jan; 28(1):198-204; discussion 204-5. PubMed ID: 8996512 [TBL] [Abstract][Full Text] [Related]